Literature DB >> 6802211

Prostaglandin endoperoxides, thromboxane A2 and adenosine diphosphate in collagen-induced aggregation of rabbit platelets.

G P Lewis, I S Watts.   

Abstract

1 A bioassay technique is described for simultaneously monitoring rabbit platelet aggregation with measurement of thromboxane A(2) (TxA(2)) and prostaglandins released in response to collagen or arachidonic acid (AA).2 Five imidazole derivatives were examined as inhibitors of thromboxane synthetase and compared with the effect of the cyclo-oxygenase inhibitor indomethacin; 1-(7-carboxyheptyl) imidazole was identified as the most potent and selective inhibitor of thromboxane synthetase and was used with indomethacin to investigate the relative contribution of the prostaglandin endoperoxides prostaglandin G(2) (PGG(2))/PGH(2) and TxA(2) in mediating platelet aggregation induced by collagen or AA.3 Platelet aggregation induced by a low concentration of collagen was abolished by indomethacin and carboxyheptylimidazole whilst in response to a high concentration or collagen only partial inhibition of aggregation occurred.4 The contribution of adenosine diphosphate (ADP) released from platelets during collagen or AA-induced aggregation was examined using the substrate/enzyme complex creatine phosphate/creatine phosphokinase (CP/CPK). The CP/CPK complex abolished aggregation induced by a low dose of collagen whilst aggregation to a high dose of collagen was only partially inhibited.5 Aggregation induced by a high dose of collagen was abolished by a combination of CP/CPK with indomethacin or carboxyheptylimidazole.6 AA-induced aggregation was abolished by indomethacin. Carboxyheptylimidazole abolished aggregation induced by a low dose of AA but inhibition was surmounted with increasing concentrations of AA in the absence of TxA(2) formation.7 PGH(2)-induced aggregation was unaffected by indomethacin and only partially inhibited by carboxyheptylimidazole. AA or PGH(2)-induced platelet aggregation was unaffected by CP/CPK.8 In conclusion, aggregation of rabbit platelets induced by a low concentration of collagen was dependent on synergism between TxA(2) and ADP whilst at high concentrations of collagen, sufficient TxA(2) and ADP were released to induce aggregation independently of each other.9 The small amounts of prostaglandin endoperoxides produced from endogenous arachidonate have apparently no direct pro-aggregatory role. However, the relatively large amount which can be produced by a high concentration of exogenous AA when TxA(2) formation is prevented can cause aggregation of rabbit platelets.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6802211      PMCID: PMC2071527          DOI: 10.1111/j.1476-5381.1982.tb09183.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  27 in total

1.  Platelet aggregation induced by arachidonic acid is accompanied by release of potential inflammatory mediators distinct from PGE2 and PGF2.

Authors:  B B Vargaftig; P Zirinis
Journal:  Nat New Biol       Date:  1973-07-25

2.  Formation of an intermediate in prostaglandin biosynthesis and its association with the platelet release reaction.

Authors:  J B Smith; C Ingerman; J J Kocsis; M J Silver
Journal:  J Clin Invest       Date:  1974-05       Impact factor: 14.808

3.  On the mechanism by which cell contact induces the release reaction of blood platelets; the effect of cationic polymers.

Authors:  P Massini; E F Lüscher
Journal:  Thromb Diath Haemorrh       Date:  1972-02-29

4.  Release of adenine nucleotides and platelet factor 4 from platelets of man and four other species.

Authors:  D P Thomas; S Niewiarowski; V J Ream
Journal:  J Lab Clin Med       Date:  1970-04

5.  Effect of acetylsalicylic acid, other nonsteroidal anti-inflammatory agents, and dipyridamole on human blood platelets.

Authors:  M B Zucker; J Peterson
Journal:  J Lab Clin Med       Date:  1970-07

6.  Arachidonic acid-induced human platelet aggregation and prostaglandin formation.

Authors:  M J Silver; J B Smith; C Ingerman; J J Kocsis
Journal:  Prostaglandins       Date:  1973-12

7.  Isolation and structure of two prostaglandin endoperoxides that cause platelet aggregation.

Authors:  M Hamberg; J Svensson; T Wakabayashi; B Samuelsson
Journal:  Proc Natl Acad Sci U S A       Date:  1974-02       Impact factor: 11.205

8.  Sodium arachidonate can induce platelet shape change and aggregation which are independent of the release reaction.

Authors:  R L Kinlough-Rathbone; H J Reimers; J F Mustard; M A Packham
Journal:  Science       Date:  1976-06-04       Impact factor: 47.728

9.  Physiological role of an endoperoxide in human platelets: hemostatic defect due to platelet cyclo-oxygenase deficiency.

Authors:  C Malmsten; M Hamberg; J Svensson; B Samuelsson
Journal:  Proc Natl Acad Sci U S A       Date:  1975-04       Impact factor: 11.205

10.  Thromboxanes: a new group of biologically active compounds derived from prostaglandin endoperoxides.

Authors:  M Hamberg; J Svensson; B Samuelsson
Journal:  Proc Natl Acad Sci U S A       Date:  1975-08       Impact factor: 11.205

View more
  9 in total

1.  Pre- and post-junctional actions of prostaglandin I2, carbocyclic thromboxane A2 and leukotriene C4 in dog tracheal tissue.

Authors:  T Inoue; Y Ito
Journal:  Br J Pharmacol       Date:  1985-02       Impact factor: 8.739

2.  LG 30435, a new bronchodilator/antiallergic agent, inhibits PAF-acether induced platelet aggregation and bronchoconstriction.

Authors:  M Criscuoli; A Subissi; L Daffonchio; C Omini
Journal:  Agents Actions       Date:  1986-11

3.  Aggregation and/or oxygenated products of arachidonic acid are not required for collagen-induced deacylation of phosphatidylcholine in human platelets.

Authors:  L A Piché; V G Mahadevappa
Journal:  Biochem J       Date:  1989-10-01       Impact factor: 3.857

4.  Stimulation of arachidonic acid metabolism and generation of thromboxane A2 by leukotrienes B4, C4 and D4 in guinea-pig lung in vitro.

Authors:  P J Piper; M N Samhoun
Journal:  Br J Pharmacol       Date:  1982-10       Impact factor: 8.739

5.  Inhibitory effect of a selective thromboxane A2 receptor antagonist, EP 092, on platelet aggregation in whole blood ex vivo and in vivo.

Authors:  R F Booth; A C Honey; N Lad; D P Tuffin; P J Wade
Journal:  Br J Pharmacol       Date:  1989-02       Impact factor: 8.739

6.  The roles of prostaglandin endoperoxides, thromboxane A2 and adenosine diphosphate in collagen-induced aggregation in man and the rat.

Authors:  H Emms; G P Lewis
Journal:  Br J Pharmacol       Date:  1986-01       Impact factor: 8.739

7.  Inhibitory effects of epigallocatechin-3-gallate on microsomal cyclooxygenase-1 activity in platelets.

Authors:  Dong-Ha Lee; Yun-Jung Kim; Hyun-Hong Kim; Hyun-Jeong Cho; Jin-Hyeob Ryu; Man Hee Rhee; Hwa-Jin Park
Journal:  Biomol Ther (Seoul)       Date:  2013-01       Impact factor: 4.634

8.  Antiplatelet and antithrombotic effects of cordycepin-enriched WIB-801CE from Cordyceps militaris ex vivo, in vivo, and in vitro.

Authors:  Hyuk-Woo Kwon; Jung-Hae Shin; Deok Hwi Lim; Woo Jeong Ok; Gi Suk Nam; Min Ji Kim; Ho-Kyun Kwon; Jun-Hee Noh; Je-Young Lee; Hyun-Hong Kim; Jong-Lae Kim; Hwa-Jin Park
Journal:  BMC Complement Altern Med       Date:  2016-12-07       Impact factor: 3.659

9.  Aspirin Reduces the Potentiating Effect of CD40L on Platelet Aggregation via Inhibition of Myosin Light Chain.

Authors:  Kevin Kojok; Mira Mohsen; Abed El Hakim El Kadiry; Walid Mourad; Yahye Merhi
Journal:  J Am Heart Assoc       Date:  2020-02-03       Impact factor: 5.501

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.